1. Introduction
===============

Pantothenate kinase associated neurodegeneration (PKAN) which is an autosomal recessive disease mutating from pantothenate kinase 2 gene (PANK2) manifests as progressive extrapyramidal dysfunction.^\[[@R1]\]^ The feature of neuroimaging is "eye of the tiger sign" which is connected with brain iron accumulation in the globus pallidus.^\[[@R2]\]^ PKAN is classified into 2 phenotypes: a "typical PKAN" with early onset (the first decade), speedy development and homogenous form in majority of the patients. An "atypical PKAN" with late onset, slow progression and variable clinical features. Compared to typical PKAN, atypical PKAN is characterized by more prominent speech problems, psychiatric symptom, much milder cognitive impairment and gait abnormalities. In addition, patients with atypical PKAN develop rarely retinopathy.

The PANK2 gene which is considered as main causative gene of PKAN is located on chromosome 20p13 and encodes pantothenate kinase-2 which plays an important role in coenzyme A (CoA) biosynthesis. It has been hypothesized that CoA deficiency due to PANK2 mutations might cause secondary accumulation of iron.^\[[@R3]\]^ But molecular mechanism of PKAN still remained unclear.

In this article, we reported the novel compound heterozygous PANK2 mutations of a Chinese boy with an atypical phenotype PKAN. In addition, we summarized clinical and genetic features of PKAN patients which were reported in Chinese population.

2. Methods
==========

2.1. Ethical approval and consent for publication
-------------------------------------------------

PANK2 gene mutation analysis was approved by the ethical committee of Sichuan University. Peripheral blood samples for total DNA extraction from the proband, his parents and100 healthy controls were obtained after conformed consent.

2.2. Detection of mutation
--------------------------

To determine all possible mutations, whole-exome sequencing (WES) in the proband was performed using IDT xGenExome Research Panel 1.0. If possible pathogenicity mutations were found in the proband, the mutations would be identified in his parents.

2.3. Review of the literature
-----------------------------

We searched for literatures about PKAN on the Chinese Biological Medicine (CBM) Database (<http://www.sinomed.ac.cn/zh/>) and PubMed. We excluded the literatures lack of genetic analysis or complete data by reading the full text and finally 9 studies^\[[@R4]--[@R12]\]^ were included in the review. The genetic and clinical features of PKAN in China were summarized.

3. Case report
==============

This proband, a 23-year-old male, was the only child of a non-consanguineous family. No history of genetic diseases was found in his family. He was born at full-term without birth injury and was in good health till the age of 11 years when he had difficulty in writing and manipulation using right hand with slow progression. Now he had to write with his left hand. By the time he was 15, he spoke with a severe stutter accentuated by tension and had bilateral hands' mild static tremor.

Examination of the nervous system revealed mild tremor with both hands and severe stutter. Both lower extremities were revealed no lesions. No gait and feeding difficulties or balance impairment or cranial nerve deficits were found. Fundus examination discloses nothing of note and the rest of the eye examinations including extraocular movements, visual acuity, visual field and pupillary evaluation were normal. He did not have cognitive problems despite poor academic performance. The score of self-rating anxiety scale was 32 which revealed mild anxiety state. In addition, his parents complained that he was irritable in life but lack of related psychological examination.

Laboratory tests including blood biochemistry, ceruloplasmin, thyroid function, parathormone, calcitonin, serum HIV antibody, syphilis antibody and autoimmune antibody were normal. Neuroimaging findings: the whole-spine magnetic resonance images (MRI) was normal. Brain computed tomography scan revealed symmetric calcifications of the bilateral globus pallidus (Fig. [1](#F1){ref-type="fig"}A). Brain T2-weighted (Fig. [1](#F1){ref-type="fig"}B) and fluid-attenuated inversion recovery (FLAIR) (Fig. [1](#F1){ref-type="fig"}C) images showed bilateral symmetrical low signal intensity in the globus pallidus with central hyperintense foci termed as "eye-of-the-tiger" sign. Brain susceptibility weighted imaging (SWI) showed bilateral symmetrical low signal in the globus pallidus which demonstrated brain iron accumulation (Fig. [1](#F1){ref-type="fig"}D).

![T2-weighted brain MRI showing the "eye-of-the-tiger" sign. (A) Brain CT scan showed a bilateral calcification of the globus pallidus; (B and C) T2 weighted and FLAIR brain MRI displayed typical "eye of the tiger"; (D) brain SWI showed bilateral symmetrical low signal in the globus pallidus. CT = computed tomography, FLAIR = fluid-attenuated inversion recovery, MRI = magnetic resonance imaging, SWI = susceptibility weighted imaging.](medi-98-e14122-g001){#F1}

Two compound heterozygous mutations c.1696C \> G and c.1160_c.1161insG respectively located on exon 7 and 3 of PANK2 were identified in the proband (Fig. [2](#F2){ref-type="fig"}). The mutation, c.1696C \> G, changed the amino acid at position 566 from leucine to valine (p.L566 V). And the mutation, c.1160_c.1161insG, denotes a frame shifting change with leucine97 as the first influenced amino acid and the new reading frame being open for 9 amino acids (p L387Lfs∗9).

![The family with compound heterozygous PANK2 gene mutations. (A) Proband with 2 compound heterozygous mutations (c.1696C \> G and c.1160_c.1161insG); (B) father with mutation (c.1696C \> G); (C) mother with mutation (c.1160_c.1161insG).](medi-98-e14122-g002){#F2}

His father and mother were respective heterozygous carriers of c.1696C \> G and c.1160_c.1161insG. In addition, we did not detect single nucleotide polymorphism in the healthy controls. Two compound heterozygous mutations in our study were absent in the 1000 Genomes Project database (<http://www.1000genomes.org/>).

4. Discussion
=============

The PANK2 gene was firstly identified as being responsible for PKAN. And for now, more than 100 mutations of this gene including aberrant splicing, missense and nonsense mutations have been reported in PKAN patients ([http://www.hgmd.org](http://www.hgmd.org/)). In this study, a Chinese 23-year-old male with a 12-year history of mainly difficulty in writing was described. Typical eye-of-the-tiger sign was presented in neuroimaging. Novel compound heterozygous mutations in exon 7 (c.1696C \> G) and 3 (c.1160_c.1161insG) of PANK2 gene were detected and were found for the first time in this study, as far as we know.

Our patient with the primary symptom of difficulty in writing and manipulation using right hand were observed when he was about 11. Then the patient developed dysarthria and tremor symptoms. Difficulty in writing with right hand has been described in a Caucasian female with atypical PKAN, which should be considered at clinical practice.^\[[@R13]\]^

Human PANK2 mainly gathered in mitochondria of neurons.^\[[@R3]\]^ Deficiency of PANK2 would cause the accumulation of cysteine-containing substrates, which lead to the generation of free radicals and trigger cell death.^\[[@R14]\]^ Most nonsense PANK2 mutations with typical form caused premature protein termination, whereas a larger proportion of missense PANK2 mutations with atypical form resulted in amino acid substitutions.^\[[@R15]\]^ In the present study, 2 novel mutations (c.1696C \> Gandc.1160_c.1161insG)of the PANK2 gene were identified. In addition, c.1160_c.1161insG and c.1696C \> G mutations were respectively considered as pathogenic and likely pathogenic according to AGMG guide. To sum up, the clinical manifestations, neuroimaging finding showing typical eye-of-the-tiger sign and the finding of 2 novel mutations on the PANK2 gene described in our patient support the clinical diagnostic criteria of atypical PKAN.

Our literature review of 12 Chinese cases suggests that PKAN is very rare in China. To date, 14 different PANK2 sequence variants have been reported in Chinese PKAN patients, the most common being missense mutations (Table [1](#T1){ref-type="table"}). These mutations of PANK2 are located in exons1--5 and 7 and intron 1. Exons 3 and 4 are frequently involved, which are the site of relatively more mutations (5 in exon 3, 3 in exon 4). Only 2 recurrent mutations (c.803A \> G occurring twice and c.1133A \> G occurring twice) were found in unrelated cases. We did not find mutation hotspots in Chinese cases, which might be associated with low PANK2 detective rate. It is reported that the missense mutation c.1583C \> T (p.T528M) in exon 6 is relatively PANK2 gene mutation hotspots observed in other countries and an apparent phenotype-genotype correlation in a cohort of homozygous c.1583C \> T Gypsy patients with a milder phenotype was identified.^\[[@R1],[@R15]--[@R18]\]^ But in Chinese cases, we did not find an evident relationship between genotype and phenotype.

###### 

Genetic features of Chinese with PANK.

![](medi-98-e14122-g003)

Our study also indicated that atypical PKAN is the more common phenotype among Chinese patients with PKAN (9/12,75%) (Table [2](#T2){ref-type="table"}). Dystonia (91.7%,) and parkinsonism (83.3%) are the core symptoms of PKAN and more common manifestation observed in Chinese series. Pyramidal signs, mental impairment, and parkinsonism had a higher prevalence among Caucasian patients. In addition, tremor and dysarthria also are frequent symptoms in our study. However, half of our PKAN patients have gait difficulty which will cause them unable to walk or need assistance, having a major effect on patients' quality of life. Although psychiatric symptoms were considered as common features of PKAN,^\[[@R19]\]^ psychiatric symptoms were not involved in other Chinese studies except our patient, which hinted that Chinese clinician should pay attention to PKAN patients' psychiatric symptoms. Cognitive impairment is more common in typical PKAN, which in line with Chinese series that cognitive impairment occurred in all 3 typical PKAN patients. Retinal changes and ocular dysmotility were not found in our series, which indicated that these symptoms were not easily involved in Chinese cases with PKAN. In short, genetic and clinical features in Chinese with PKAN still remain to be summarized due to a limited number of cases reported at present.

###### 

Clinical characteristics of Chinese with PANK.
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We identified 2 novel mutations in the PANK2 gene in PKAN patient, which expands the inventory of PANK2 mutations involved in PKAN. This review of the reports indicated that atypical PKAN is the more common phenotype in China and also provide a more complete gene mapping in the Chinese population with PKAN, although PKAN is uncommon in China. In addition, no apparent genotype--phenotype correlation was found.
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